no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Adult-onset idiopathic Type I or ketosis-prone Type II diabetes: evidence to revisit diabetes classification
|
Sobngwi, E. |
|
2002 |
45 |
2 |
p. 283-285 |
article |
2 |
Adult-onset idiopathic Type I or ketosis-prone Type II diabetes: evidence to revisit diabetes classification
|
Sobngwi, E. |
|
2002 |
45 |
2 |
p. 283-285 |
article |
3 |
Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy
|
Hogeboom van Buggenum, I. M. |
|
2002 |
45 |
2 |
p. 203-209 |
article |
4 |
Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy
|
Hogeboom van Buggenum, I. M. |
|
2002 |
45 |
2 |
p. 203-209 |
article |
5 |
Announcement
|
|
|
2002 |
45 |
2 |
p. R9-R12 |
article |
6 |
A phosphodiesterase inhibitor, cilostazol, prevents the onset of silent brain infarction in Japanese subjects with Type II diabetes
|
Shinoda-Tagawa, T. |
|
2002 |
45 |
2 |
p. 188-194 |
article |
7 |
A phosphodiesterase inhibitor, cilostazol, prevents the onset of silent brain infarction in Japanese subjects with Type II diabetes
|
Shinoda-Tagawa, T. |
|
2002 |
45 |
2 |
p. 188-194 |
article |
8 |
Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice
|
Shapiro, A. M. J. |
|
2002 |
45 |
2 |
p. 224-230 |
article |
9 |
Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice
|
Shapiro, A. M. J. |
|
2002 |
45 |
2 |
p. 224-230 |
article |
10 |
Complete glucokinase deficiency is not a common cause of permanent neonatal diabetes
|
Gloyn, A. L. |
|
2002 |
45 |
2 |
p. 290 |
article |
11 |
Considerations for successful transplantation of encapsulated pancreatic islets
|
de Vos, P. |
|
2002 |
45 |
2 |
p. 159-173 |
article |
12 |
Considerations for successful transplantation of encapsulated pancreatic islets
|
de Vos, P. |
|
2002 |
45 |
2 |
p. 159-173 |
article |
13 |
Decreased matrix degradation in diabetic nephropathy: effects of ACE inhibition on the expression and activities of matrix metalloproteinases
|
McLennan, S. V. |
|
2002 |
45 |
2 |
p. 268-275 |
article |
14 |
Decreased matrix degradation in diabetic nephropathy: effects of ACE inhibition on the expression and activities of matrix metalloproteinases
|
McLennan, S. V. |
|
2002 |
45 |
2 |
p. 268-275 |
article |
15 |
Erratum to: Advanced glycation end-products: a review
|
Singh, R. |
|
2002 |
45 |
2 |
p. 293 |
article |
16 |
Erratum to: Diabetes mellitus and the stomach
|
Stacher, G. |
|
2002 |
45 |
2 |
p. 293 |
article |
17 |
Islet autoantibodies, nationality and gender: a multinational screening study in first-degree relatives of patients with Type I diabetes
|
Williams, A. J. K. |
|
2002 |
45 |
2 |
p. 217-223 |
article |
18 |
Islet autoantibodies, nationality and gender: a multinational screening study in first-degree relatives of patients with Type I diabetes
|
Williams, A. J. K. |
|
2002 |
45 |
2 |
p. 217-223 |
article |
19 |
Kidney function and glomerulopathy over 8 years in young patients with Type I (insulin-dependent) diabetes mellitus and microalbuminuria
|
Bangstad, H.-J. |
|
2002 |
45 |
2 |
p. 253-261 |
article |
20 |
Kidney function and glomerulopathy over 8 years in young patients with Type I (insulin-dependent) diabetes mellitus and microalbuminuria
|
Bangstad, H.-J. |
|
2002 |
45 |
2 |
p. 253-261 |
article |
21 |
Kinetics of integrin expression in the mouse model of proliferative retinopathy and success of secondary intervention with cyclic RGD peptides
|
Chavakis, E. |
|
2002 |
45 |
2 |
p. 262-267 |
article |
22 |
Kinetics of integrin expression in the mouse model of proliferative retinopathy and success of secondary intervention with cyclic RGD peptides
|
Chavakis, E. |
|
2002 |
45 |
2 |
p. 262-267 |
article |
23 |
Losartan attenuates endothelial hyperpermeability responses to VPF and high glucose but not angiotensin II
|
Idris, I. |
|
2002 |
45 |
2 |
p. 291-292 |
article |
24 |
Metabotropic glutamate and GABAB receptors contribute to the modulation of glucose-stimulated insulin secretion in pancreatic beta cells
|
Brice, N. L. |
|
2002 |
45 |
2 |
p. 242-252 |
article |
25 |
Metabotropic glutamate and GABAB receptors contribute to the modulation of glucose-stimulated insulin secretion in pancreatic beta cells
|
Brice, N. L. |
|
2002 |
45 |
2 |
p. 242-252 |
article |
26 |
Polymorphism in the Calpain 10 gene influences glucose metabolism in human fat cells
|
Hoffstedt, J. |
|
2002 |
45 |
2 |
p. 276-282 |
article |
27 |
Polymorphism in the Calpain 10 gene influences glucose metabolism in human fat cells
|
Hoffstedt, J. |
|
2002 |
45 |
2 |
p. 276-282 |
article |
28 |
Relation between glycaemic control, hyperinsulinaemia and plasma concentrations of soluble adhesion molecules in patients with impaired glucose tolerance or Type II diabetes
|
Blüher, M. |
|
2002 |
45 |
2 |
p. 210-216 |
article |
29 |
Relation between glycaemic control, hyperinsulinaemia and plasma concentrations of soluble adhesion molecules in patients with impaired glucose tolerance or Type II diabetes
|
Blüher, M. |
|
2002 |
45 |
2 |
p. 210-216 |
article |
30 |
Syntaxin-3 and syntaxin-1A inhibit L-type calcium channel activity, insulin biosynthesis and exocytosis in beta-cell lines
|
Kang, Y. |
|
2002 |
45 |
2 |
p. 231-241 |
article |
31 |
Syntaxin-3 and syntaxin-1A inhibit L-type calcium channel activity, insulin biosynthesis and exocytosis in beta-cell lines
|
Kang, Y. |
|
2002 |
45 |
2 |
p. 231-241 |
article |
32 |
The Author's Reply
|
Lindner, T. H. |
|
2002 |
45 |
2 |
p. 287-288 |
article |
33 |
The Author's Reply
|
Wilkin, T. |
|
2002 |
45 |
2 |
p. 289 |
article |
34 |
The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new long-acting GLP-1 derivative, in healthy men
|
Agersø, H. |
|
2002 |
45 |
2 |
p. 195-202 |
article |
35 |
The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new long-acting GLP-1 derivative, in healthy men
|
Agersø, H. |
|
2002 |
45 |
2 |
p. 195-202 |
article |
36 |
- to: Lindner T, Cockburn BN, Bell GI (1999) Molecular genetics of MODY in Germany. Diabetologia 42: 121–123
|
Ziemssen, F. |
|
2002 |
45 |
2 |
p. 286-287 |
article |
37 |
- to: T. J. Wilkin (2001) The accelerator hypothesis: weight gain as the missing link between Type I and Type II diabetes. Diabetologia 44: 914–921
|
Gorus, F. K. |
|
2002 |
45 |
2 |
p. 288-289 |
article |
38 |
Uncoupling protein-2: evidence for its function as a metabolic regulator
|
Saleh, M. C. |
|
2002 |
45 |
2 |
p. 174-187 |
article |
39 |
Uncoupling protein-2: evidence for its function as a metabolic regulator
|
Saleh, M. C. |
|
2002 |
45 |
2 |
p. 174-187 |
article |